Health Canada open data (page 48)
Health Canada publishes 2,987 open datasets on CanQuery: 58 with live tables. Preview tables, export CSV and follow original downloads.
- Datasets
- 2987
- Queryable datasets
- 58
- Mappable datasets
- 0
Datasets
- Trade Memorandum: Efficacy Data for Antimicrobial Products
- Regulatory Directive: Efficacy Guidelines for Plant Protection Products
- Regulatory Directive: Pre-harvest Intervals for Grazing and Cutting for Hay of Immature Crops Treated with Pesticides
- Regulatory Directive: Guidelines for Developing a Toxicological Database for Chemical Pest Control Products
- Regulatory Directive: Administrative Process for a Change in a Registrant's Name or a Change in Registrant for Pest Control Products
- Regulatory Directive: Protection of Proprietary Interests in Pesticide Data in Canada
- Regulatory Directive: Requirements for Submitting Data Index, Documents and Forms
- Regulatory Directive: Guidelines for the Registration of Microbial Pest Control Agents and Products
- PMRA program renewal
- Pesticide compliance and enforcement
- Pollinator Protection
- Sustainable Pest Management
- Conditional Registrations
- Mandatory Incident Reporting for Registrants and Applicants
- Report a Pesticide Incident
- Swimming pool and spa chemicals
- Using pesticides on your lawn
- Pest control tips
- Personal Insect repellents
- Protecting Your Health and the Environment
- Pesticide safety
- Pesticides and food safety
- Public Registry: Pesticide Product Information Database
- Use pesticides safely
- Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements
- Guidance for market authorization requirements for COVID-19 vaccines: Review process, communications and transparency
- Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Overview
- Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Preparing a submission or supplement
- Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Drug establishment licences and good manufacturing practices
- Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Post-market requirements
- Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Pre-positioning of COVID-19 drugs
- Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Intellectual property
- Guidance on safety and performance specifications for filtering facepiece respirators (FFRs) during COVID-19: Background
- Guidance on safety and performance specifications for filtering facepiece respirators (FFRs) during COVID-19: Overview
- Guidance on safety and performance specifications for filtering facepiece respirators (FFRs) during COVID-19: Performance criteria
- Guidance on safety and performance specifications for filtering facepiece respirators (FFRs) during COVID-19: Other items for an interim order submission
- Moderna COVID-19 vaccine: Authorized with conditions
- Moderna COVID-19 vaccine: Continued monitoring
- Moderna COVID-19 vaccine: What you should know
- Medical devices for uses related to COVID-19
- Guidance for market authorization requirements for COVID-19 vaccines: Labelling and post-market requirements
- Guidance for market authorization requirements for COVID-19 vaccines: Requirements for vaccines to address SARS-CoV-2 variants
- Guidance for market authorization requirements for COVID-19 vaccines: Rolling submissions, non-clinical and clinical requirements
- Guidance for market authorization requirements for COVID-19 vaccines: Overview
- FDA guidance: Template for manufacturers of molecular and antigen diagnostic COVID-19 tests for non-laboratory use
- Exceptional importation and sale of medical devices in relation to COVID-19: Overview
- Drugs and vaccines for COVID-19: List of authorized clinical trials
- Exceptional importation and sale of drugs in relation to COVID-19: Overview
- Drugs and vaccines for COVID-19
- Ensuring predictability for COVID-19 clinical trials and proposal for clinical trials records retention: Notice to stakeholders